AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
AbbVie has agreed to buy Apogee Therapeutics for about $10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation portfolio.
Connecting Global Economies
Flash News
The Club’s top 10 things to watch in the stock market Monday
Gordon Ramsay’s Daughter Holly Ramsay Pregnant
Five burning NBA Draft questions, including who’ll go No. 1 and the guard puzzle
Iran agrees to invite IAEA inspectors back, says US
States pressured to cut red tape. Data center-wary voters may disagree
Summer House’s Danielle Olivera Welcomes First Baby 10 Weeks Early
For Suns’ Devin Booker, new number opens new chapter in search of better ending
Alan Greenspan, former US Fed Reserve chair, dies aged 100
Alan Greenspan, former chairman of the Fed, dies at age 100
Nicole Kidman Shares Father’s Day Shoutout to Ex Keith Urban
Monday, June 22, 2026